Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.oraloncology.2024.106776 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The future of healthcare for cardiovascular diseases holds immense promise, not only based in new discoveries in cardiac metabolism but also in translating them to solutions for critical challenges faced by society. Here, ten scientists share their insights, shedding light on the future that lies ahead for this field.
View Article and Find Full Text PDFWhat's ahead for complete responders following NACT?
Oral Oncol
May 2024
Health Care Global Enterprises Ltd. Hospital Bengaluru, Karnataka, India. Electronic address:
Women empowerment in perioperative period: What's done and the way ahead!
Indian J Anaesth
November 2023
Department of Anaesthesiology, Kalyan Singh Super Speciality Cancer Institute, Lucknow, Uttar Pradesh, India.
Anxiety in Parkinson's Patients: What's Timing Got to Do with It?
J Geriatr Psychiatry Neurol
November 2023
Department of Health & Clinical Outcomes Research, Saint Louis University School of Medicine, St. Louis, MO, USA.
Parkinson's Disease (PD) affects over 10 million people worldwide. Many PD patients experience comorbid anxiety disorders, which have been correlated with reduced quality of life and can manifest at any time during the course of PD, including prior to motor symptom onset. Prior work has demonstrated that patients diagnosed with depression following a PD diagnosis are less likely to receive depression treatment, but no such study has been conducted for anxiety.
View Article and Find Full Text PDFMessenger RNA-Based Therapeutics and Vaccines: What's beyond COVID-19?
ACS Pharmacol Transl Sci
July 2023
CAS, a division of the American Chemical Society 2540 Olentangy River Rd, Columbus, Ohio 43202, United States.
With the rapid success in the development of mRNA vaccines against COVID-19 and with a number of mRNA-based drugs ahead in the pipelines, mRNA has catapulted to the forefront of drug research, demonstrating its substantial effectiveness against a broad range of diseases. As the recent global pandemic gradually fades, we cannot stop thinking about what the world has gained: the realization and validation of the power of mRNA in modern medicine. A significant amount of research has now been concentrated on developing mRNA drugs and vaccine platforms against infectious and immune diseases, cancer, and other debilitating diseases and has demonstrated encouraging results.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!